NCT07161011View on ClinicalTrials.gov

Phase 2b Controlled Study of Dosing Techniques - Part B

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Dry Eye
Interventions
DRUG

IVW-1001 Ophthalmic Eyelid Wipe 0.2%

Low dose

DRUG

IVW-1001 Ophthalmic Eyelid Wipe 0.4%

High dose

Trial Locations (1)

92663

Eye Research Foundation, Newport Beach

Sponsors
All Listed Sponsors
lead

IVIEW Therapeutics Inc.

INDUSTRY